InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: Lemoncat post# 376687

Thursday, 09/30/2021 10:29:28 AM

Thursday, September 30, 2021 10:29:28 AM

Post# of 402714
Obviously UNTRUE...IMO just the opposite...

Compassionate Use Patients = CRITICAL CONDITION...likely days away from dying...and likely going on or on ventilators...

IMO...in spite of the condition and even death post due to ORGAN FAILURE FROM COVID ravaging their system... Brilacidin's effects against COVID will be evident...i.e eliminating the virus in the patient even patients on the cusp of death...eliminating the additional strain of the virus while the organs attempt to heal themselves...

It would be logical to assume that the younger the Critical Condition patient the more chance of survival...but much will be learned.

IMO...based upon PR's and RBL...we will find via the several (or more) Compassionate Use cases the board via FB has apparently learned about...BRILACIDIN demonstrates POSITIVE SYSTEMIC EFFECTS...even IF a patient expires.

ON THE OTHER HAND... the Brilacidin concluded CLINICAL TRIAL is populated with ONLY "moderate to severe"...likely NOT LIKELY WITH PATIENTS WHOSE ORGANS ARE LIKELY DAMAGED FROM COVID..."beyond no return" experienced by CRITICALLY ILL Patients...according to the protocol they were not in critical condition...and therefore the healthier, likely less organ impairment, and more opportunity for Brilacidin to do its wonders is afforded...

IMO look for great results shortly!...and

Know what your own!

GLTAL (Longs)

PS. Effectively eliminating the VIRUS while assisting the body opportunity to repair organs...is what a Therapeutic is supposed to do... It's NOT a Heart, Liver, Lung, or Kidney medicine, but it can aid attempts by the body by eliminating the Virus and its deleterious effects on those organs...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News